News

New member | LaFleur by DelleD

While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article

Update on XENOTHERA’s news

In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article

New member | Bioprox Healthcare

BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article

New member | Genourob

Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article

Valneva reports positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate

VLA2001 was well tolerated with no safety concerns identified In the high dose group : IgG seroconversion rate of 100%... View Article

OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine

CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article

Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre

With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article